|
Lucas, R. Recent advances on the role of the endothelium in pulmonary function and disease. Vascul Pharmacol. 2008 Jul 19. [Epub ahead of print]
Hundsberger, H, Verin A, Wiesner C, Pflueger M, Dulebo A, Schuett W, Maennel D, Wendel A and Lucas R. TNF: a moonlighting protein at the interface between cancer and infection. Frontiers in Biosc. 2008, 13:5374-86.
Latta M; Kuenstle G; Lucas R; Hentze H and Wendel A. ATP-dependent carbohydrates prevent TNF Receptor 1-dependent apoptotic and necrotic liver injury in mice. JPET 2007. 321(3): 1-9.
Lucas R; Hundsberger H; Braun C; Wendel A; Chakraborty T; Wiesner C and Hamacher J. The TNF-derived TIP peptide: a potential anti-edema drug. Letters in Drug Discovery and Design. 2007, 4(5):.336-340.
Furstenberger G, von Moos R, Lucas R, Thurlimann B, Senn HJ, Hamacher J, Boneberg EM. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. 2006. Br J Cancer; 94(4):524-531.
Braun, C; Hamacher, J; Morel, D; Wendel, A; and Lucas R. Dichotomal Role of TNF in Experimental Pulmonary Edema Reabsorption. 2005. Journal of Immunology 175(5). 3402-3408.
Kresse, M; Latta, M; Kunstle, G; Riehle H-M; van Rooijen, N; Hentze, H; Tiegs, G; Biburger, M; Lucas, R. and Wendel A. Kupffer Cell expressed Membrane-Bound TNF mediates Melphalan hepatotoxicity via activation of both TNF Receptors. 2005. Journal of Immunology 175(6).4076-4083.
Weiller, M; Latta, M; Kresse, M; Lucas, R and Wendel A. Toxicity of nutritionally available selenium compounds in primary and transformed hepatocytes. Toxicology 2004, 201(1-3):21-30.
Elia, N; Tapponnier, M; Matthay, MA; Hamacher, J; Pache, J-C; Bründler, MA; Totsch, M; De Baetselier, P; Fransen, L; Fukuda, N; Morel, DR and Lucas R. Identification of the alveolar edema reabsorption activity of murine Tumor Necrosis Factor. AJRCCM 2003, 168: 1043-1050 (editorial in November 1st issue)
Xu, J; Lucas, R; Schuchmann, M; Kühnle, S; Meergans, T; Barreiros, AP; Lohse, A; Otto, G and Wendel A. GM-CSF restores innate, but not adaptive immune responses in glucocorticoid-immunosuppressed human blood in vitro. J. Immunol. 2003, 171: 938-947.
Hamacher, J; Lucas, R; Lijnen, HR; Buschke, S; Dunant, Y; Wendel , A; Grau, GE; Suter, PM and Ricou B. Tumor necrosis factor and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. AJRCCM 2002; 166: 651-656.
Lucas, R; Lijnen, HR; Suffredini, AF; Pepper, MS; Steinberg, KP; Martin, TR and Pugin J. Increased angiostatin levels in bronchoalveolar lavage fluids from ARDS patients and from human volunteers after lung instillation of endotoxin. Thrombosis and Haemostasis. 2002; 87: 966-972.
Fukuda, N; Jayr, C; Lazrak, A; Wang, Y; Lucas, R; Matalon, S; Matthay, MA. Mechanisms of TNF-stimulation of amiloride sensitive sodium transport across the alveolar epithelium in vivo and epithelial cells in vitro. Am. J. Physiol. 2001; 280(6): L1258-L1265.
Lucas, R; Montesano, R; Pepper, MS; Hafner, M; Sablon, E; Dunant, Y; Grau, GE; De Baetselier, P; Maennel, D; Fransen L. Lectin-deficient TNF mutants display comparable anti-tumour but reduced pro-metastatic potential as compared to the wild-type molecule. Int J Cancer. 2001; 15;91(4):543-549.
Lucas, R; Tacchini-Cottier, F; Guler, R; Vesin, D; Jemelin, S; Olleros, ML; Marchal, G; Browning, JL; Vassalli, P; Garcia I. A role for lymphotoxin beta receptor in host defense against Mycobacterium bovis BCG infection. Eur. J. Immunol. 1999; 29(12):4002-4010.
Favre, N; Da Laperousaz, C; Ryffel, B; Weiss, NA; Imhof, BA; Rudin, W; Lucas, R; Piguet PF. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1999; 1(12):961-968.
van der Goot, FG; Pugin, J; Hribar, M; Fransen, L; Dunant, Y; De Baetselier, P; Bloc, A; Lucas R. Membrane interaction of TNF is not sufficient to trigger increase in membrane conductance in mammalian cells. FEBS Lett. 1999; 460(1):107-111.
Hribar, M; Bloc, A; van der Goot, FG; Fransen, L; De Baetselier, P; Grau, GE; Bluethmann, H; Matthay, MA; Dunant, Y; Pugin, J; Lucas R. The lectin-like domain of tumor necrosis factor-alpha increases membrane conductance in microvascular endothelial cells and peritoneal macrophages. Eur. J. Immunol. 1999; 29(10):3105-3111.
Truyens, C; Torrico, F; Lucas, R; De Baetselier, P; Buurman, WA; Carlier, Y. The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infect Immun. 1999; 67(11):5579-5586.
Beschin, A; Bilej, M; Brys, L; Torreele, E; Lucas, R; Magez, S; De Baetselier P. Convergent evolution of cytokines. Nature. 1999; 400(6745):627-628.
Lucas, R; Holmgren, L; Garcia, I; Jimenez, B; Mandriota, SJ; Borlat, F; Sim, BK; Wu, Z; Grau, GE; Shing, Y; Soff, GA; Bouck, N; Pepper MS. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood. 1998; 92(12):4730-4741.
Lucas, R; Garcia, I; Donati, YR; Hribar, M; Mandriota, SJ; Giroud, C; Buurman, WA; Fransen, L; Suter, PM; Nunez, G; Pepper, MS; Grau GE. Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells. Eur J Immunol. 1998; 28(11):3577-3586.
Olivares-Fontt, EO: De Baetselier, P; Heirman, C; Thielemans, K; Lucas, R; Vray B. Effects of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha on Trypanosoma cruzi trypomastigotes. Infect Immun. 1998; 66(6):2722-2727.
Lucas, R; Juillard, P; Decoster, E; Redard, M; Burger, D; Donati, Y; Giroud, C; Monso-Hinard, C; De Kesel, T; Buurman, WA; Moore, MW; Dayer, JM; Fiers, W; Bluethmann, H; Grau GE. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol. 1997; 27(7):1719-1725.
Lou, J ; Ythier, A ; Burger, D; Zheng, L ; Juillard, P ; Lucas, R ; Dayer, JM ; Grau GE. Modulation of soluble and membrane-bound TNF-induced phenotypic and functional changes of human brain microvascular endothelial cells by recombinant TNF binding protein I. J Neuroimmunol. 1997; 77(1):107-115.
Lucas, R; Echtenacher, B; Sablon, E; Juillard, P; Magez, S; Lou, J; Donati, Y; Bosman, F; Van de Voorde, A; Fransen, L; Mannel, DN; Grau, GE; de Baetselier P. Generation of a mouse tumor necrosis factor mutant with antiperitonitis and desensitization activities comparable to those of the wild type but with reduced systemic toxicity. Infect Immun. 1997; 65(6):2006-2010.
Magez, S; Geuskens, M; Beschin, A; del Favero, H; Verschueren, H; Lucas, R; Pays, E; de Baetselier P. Specific uptake of tumor necrosis factor-alpha is involved in growth control of Trypanosoma brucei. J Cell Biol. 1997; 137(3):715-727.
Lucas, R ; Lou, JN; Juillard, P ; Moore, M ; Bluethmann, H ; Grau GE. Respective role of TNF receptors in the development of experimental cerebral malaria. J Neuroimmunol. 1997; 72(2):143-148.
Sekine-Okano, M; Lucas, R; Rungger, D; De Kesel, T; Grau, GE; Leuenberger, PM; Rungger-Brandle E. Expression and release of tumor necrosis factor-alpha by explants of mouse cornea. Invest Ophthalmol Vis Sci. 1996; 37(7):1302-1310.
Grau, GE ; Mili, N ; Lou, JN ; Morel, DR ; Ricou, B ; Lucas, R; Suter PM. Phenotypic and functional analysis of pulmonary microvascular endothelial cells from patients with acute respiratory distress syndrome. Lab Invest. 1996; 74(4):761-770.
Truyens, C; Torrico, F; Angelo-Barrios, A; Lucas, R; Heremans, H; De Baetselier, P; Carlier Y. The cachexia associated with Trypanosoma cruzi acute infection in mice is attenuated by anti-TNF-alpha, but not by anti-IL-6 or anti-IFN-gamma antibodies. Parasite Immunol. 1995; 17(11):561-568.
Garcia, I; Miyazaki, Y; Araki, K; Araki, M; Lucas, R; Grau, GE; Milon, G; Belkaid, Y; Montixi, C; Lesslauer, W and Vassalli P. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur J Immunol. 1995; 25(8):2401-2407.
Rivera, MT ; Marques de Araujo, S ; Lucas, R ; Deman, J ; Truyens, C ; Defresne, MP ; de Baetselier, P ; Carlier Y. High tumor necrosis factor alpha (TNF-alpha) production in Trypanosoma cruzi-infected pregnant mice and increased TNF-alpha gene transcription in their offspring. Infect Immun. 1995; 63(2):591-595.
Bilej, M; Brys, L; Beschin, A ; Lucas, R; Vercauteren, E; Hanusova, R; De Baetselier P. Identification of a cytolytic protein in the coelomic fluid of Eisenia foetida earthworms. Immunol Lett. 1995; 45(1-2):123-128.
Lucas, R; Magez, S; De Leys, R; Fransen, L; Scheerlinck, JP; Rampelberg, M; Sablon, E; De Baetselier P. Mapping the lectin-like activity of tumor necrosis factor. Science. 1994; 263(5148):814-817.
Magez, S; Lucas, R; Darji, A; Songa, EB; Hamers, R; De Baetselier P. Murine tumour necrosis factor plays a protective role during the initial phase of the experimental infection with Trypanosoma brucei brucei. Parasite Immunol. 1993; 15(11):635-641.
Zanetti, G; Heumann, D; Gerain, J; Kohler, J; Abbet, P; Barras, C; Lucas, R; Glauser MP, *Baumgartner JD. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide. J Immunol. 1992; 148(6):1890-1897.
Vanhaesebroeck, B; Van Bladel, S; Lenaerts, A; Suffys, P; Beyaert, R; Lucas, R; Van Roy, F; Fiers W. Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line. Cancer Res. 1991; 51(9):2469-2477.
Lucas, R; Heirwegh, K; Neirynck, A; Remels, L; Van Heuverswyn, H; De Baetselier P. Generation and characterization of a neutralizing rat anti-rmTNF-alpha monoclonal antibody. Immunology. 1990; 71(2):218-223.
Lucas, R and Keisari Y. Innovative cancer therapies that combine chemotherapy or radiotherapy with immunotherapy. 2006. Recent Patents on Anti-Cancer Drug Discovery.
Lucas, R. Preclinical evaluation of a TNF-derived peptide in models of experimental pulmonary edema. 2005. Pharmaceutical Manufacturing and Packing Sourcer.
Lucas, R. Interview: Role of TNF in pulmonary edema reabsorption. 2005. Modern Aspects of Immunobiology.
Lucas, R; Kresse, M; Latta, M and Wendel A. Tumor Necrosis factor: How to make a killer molecule Tumor-specific? 2005. Current Cancer Drug Targets 5. 381-392.
Xu, J; Lucas, R and Wendel A. The potential of GM-CSF to improve resistance against infections in organ transplantation: a new tune for an old song ? Trends in Pharmacol. Sci. 2004; 25(5):254-258.
Xu, J; von Aulock, S; Lucas, R and Wendel A. Colony-stimulating factors: improvement of different anti-infectious defence mechanisms. Invited review. Current Opin. In Organ Transpl. 2004
Beschin, A; Bilej, M; Magez, S; Lucas, R and De Baetselier P. Functional convergence of invertebrate and vertebrate cytokine-like molecules based on a similar lectin-like activity. Prog Mol Subcell Biol. 2004; 34:145-163.
Hentze H, Latta M, Kuenstle G, Lucas R and Wendel A. Redox control of hepatic cell death. Toxicol. Lett. 2003; 139, 111-118.
Lucas, R; Grau, GE; Matthay, MA and Wendel A. Functional role of TNF in liver, brain and lungs. Current Trends in Immunol. 2002; 4: 47-59.
Lou, J; Lucas, R and Grau GE. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev. 2001; 14(4):810-820.
Lucas, R; Lou, J; Morel, DR; Ricou, B; Suter, PM; Grau GE. TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria. J Leukoc Biol. 1997; 61(5):551-558.
Lucas, R; Magez, S; Songa, B; Darji, A; Hamers, R; de Baetselier P. A role for TNF during African trypanosomiasis: involvement in parasite control, immunosuppression and pathology. Res Immunol. 1993; 144(5):370-376.
Darji, A; Lucas, R; Magez, S; Torreele, E; Palacios, J; Sileghem, M; Bajyana Songa, E; Hamers, R; De Baetselier P. Mechanisms underlying trypanosome-elicited immunosuppression. Ann Soc Belg Med Trop. 1992; 72 Suppl 1:27-38.
Lucas R, Xu J, Braun C, Leja A, Meergans T, Hamacher J and Wendel A. Tumor Necrosis Factor in bacterial and parasitic infections: to be or not to be? In Recent Res. Devel. Infection & Immunity, 1. 2003: 303-316.
Latta M, Kresse M, Künstle G, Lucas R and Wendel A. Models of cytokine-induced hepatic failure. Disease Progression and Carcinogenesis in the Gastro-intestinal Tract, 2003. Editors, PR Galle, WE Schmidt, G. Gerken, B. Wiedenmann. Kluwer Academic Publishers.
Lucas R, Suter PM and Grau GE. TNF in the microvascular pathology of septic shock and cerebral malaria. Annual Year Book of Intensive Care and Emergency Medecine, 1997. Editor, JL Vincent. Springer Verlag.
Lucas R, Magez S, De Leys R and De Baetselier P. Cytokines: Multifunctional pathogen-specific mammalian lectins? In: Lectins: Biology, Biochemistry, Clinical Biochemistry-Volume 10, 1994. Editors, Van Driessche, Fischer, Beeckmans, Bög-Hansen., 244-249.
LEP0682705/WO9418325: TNF muteins and a process for preparing them. Innogenetics, Belgium, Inventor
EP1105152/WO0009141: TNF-derived peptides for use in treating edema. Apeptico, Austria, Inventor
|